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ABSTRACT 
A series of some new 1,3,5-trisubstituted pyrazoles was synthesized by the reaction of α-β dibromochalcones with phenylhydrazine 
hydrochloride. α-β-Dibromochalcones were prepared by the regioselective bromination of respective chalcones with tetrabutylammonium 
tribromide. The synthesized trisubstituted pyrazoles were evaluated for their anti-inflammatory and antioxidant properties. 
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Pyrazoles are one of the most valuable heterocycles as they 
are potential bioactive agents due to their wide spectrum of 
pharmacological activities like anti-inflammatory, 
antimicrobial, calcium channel blockers, antihypertensive, 
analgesic, antitumor, antiviral, antibacterial, anticancer, 
antimalarial, antitubercular, hypoglycemic etc.1-4 Pyrazoles 
are also useful as catalysts5 ,ligands6 or as moieties to 
increase regio- and stereoselectivity7 and as an 
intermediates for the synthesis of various fused pyrazoles8.  
Chalcones act as a fine reactant for the synthesis of various 
different heterocyclic rings. Pyrazoles derived from 
chalcones are of great interest because of their different 
biological and pharmacological properties. α-β-
Dibromochalcones are active intermediates in the synthesis 
of biologically active cyclic compounds like pyrazoles, 
pyrazolines and isoxazoles etc. hey have served as valuable 
substrates to bring about a variety of chemical reactions.9-15 
 In view of the above facts, the present study encourages the 
synthesis of 1,3,5-trisubstituted pyrazole derivatives from α-
β-Dibromochalcones which can be prepared by using 
bromine or N-bromosuccinimide in the weakly polar aprotic 
solvents like CCl4, CHCl3, CH2Cl2 but yields are very 
limited.16,17 So, the use of tetrabutylammonium tribromide 
(TBABr3) causes regioselective bromination of chalcones 
and gives high yield without polymerization. TBABr3 is easy 
to use under mild conditions and unlike bromine it is neither 
corrosive nor toxic. It is prepared by the addition of 
hydrobromic acid to an aqueous solution of tetrabutyl 
ammonium bromide and sodium bromide at room 
temperature.18 
RESULTS AND DISCUSSION 
Synthesis 
Various derivatives of α-β-Dibromochalcones were prepared 
by the reaction of different chalcones (I) with 
tetrabutylammonium tribromide (TBABr3). These α-β-
Dibromochalcones (V1B1-V7B7) were treated with 
phenylhydrazine hydrochloride to give different 1,3,5-
trisubstituted pyrazoles (V1B1PH1-V7B7PH7)(Scheme 
1).Physical data of the synthesized compounds are given in 
the Table 1& 2.The reaction gave single colorless product 
and a good yield in the range 65-72%. The compounds were 
purified by recrystallization from ethanol and dried under 
vacuum. The synthesized compounds were characterized by 
IR, 1NMR and elemental analysis. 
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Scheme 1: Synthetic sequence of α-β  chalcone dibromides and 1,3,5 trisubstituted Pyrazole 
Table 1: Physical data of α-β-Dibromochalcones 
Sr No. Compound  Ar Ar’ Melting Point(0C) Yield (%) 
1 V1B1 C10H7 C6H5 104-106 76 
2 V2B2 C10H7 4-ClC6H4 108-110 75 
3 V3B3 C10H7 4-NO2C6H4 94-96 68 
4 V4B4 C10H7 4-MeOC6H4 121-123 63 
5 V5B5 C10H7 4-FC6H4 145-147 70 
6 V6B6 C10H7 4-MeC6H4 132-134 66 
7 V7B7 C10H7 4-OHC6H4 118-120 69 
 
Table 2: Physical data of 1,3,5 trisubstituted pyrazoles 
Sr No. Compound  Ar Ar’ Melting Point(0C) Yield (%) 
1 V1B1PH1 C10H7 C6H5 112-114 65 
2 V2B2PH2 C10H7 4-ClC6H4 102-104 69 
3 V3B3PH3 C10H7 4-NO2C6H4 110-112 72 
4 V4B4PH4 C10H7 4-MeOC6H4 126-128 73 
5 V5B5PH5 C10H7 4-FC6H4 105-107 69 
6 V6B6PH6 C10H7 4-MeC6H4 116-117 72 
7 V7B7PH7 C10H7 4-OHC6H4 130-132 70 
 
Biological Evaluation 
In Vitro Antioxidant Activity 
 DPPH (1,1-diphenyl-2-picrylhydrazyl) free radical 
scavenging method was used for the determination of 
antioxidant activity. The test compound was mixed with 95% 
methanol to make a stock solution of concentration 
100μg/ml. From stock solution different solutions of 
concentration 10μg/ml, 20μg/ml, 40μg/ml, 60μg/ml and 
100μg/ml were prepared. Ascorbic acid was used as a 
standard and different concentrations of the standard were 
prepared as that of the test compound. The reaction mixture 
containing 1ml of 0.3mmol DPPH methanol solution was 
added to 2.5ml of sample solution of different concentrations 
and allowed to react at room temperature. After 15min. 
incubation period at 370C absorbance was calculated at 
517nm. Control reading was observed without the test 
compound. 
% scavenging = [(Absorbance of control- Absorbance of test 
compound)/ (Absorbance of control)] X 100 
The free radical scavenging activity of the synthesized 
compounds were evaluated through the ability of the 
compounds to quench the DPPH using ascorbic acid as a 
standard.   
The results are given in the table 3. All the synthesized 
compounds were less potent than the standard. The 
compounds V5B5PH5 and V7B7PH7 exhibited moderate 
antioxidant activity in comparison to the standard. 
 
Table 3:  Antioxidant activity of the 1,3,5 trisubstituted Pyrazoles by using DPPH free radical scavenging method 
Sr. No. Compound                                  % Inhibition Antioxidant IC50 value 
  10μg/ml 20μg/ml 40μg/ml 60μg/ml 100μg/ml  
1 V1B1PH1 2.48 6.89 18.88 26.34 33.78 137.67 
2 V2B2PH2 1.25 8.98 12.55 19.98 22.35 213.37 
3 V3B3PH3 2.88 3.04 13.80 18.65 24.09 194.29 
4 V4B4PH4 24.8 31.98 37.63 43.66 51.76 88.45 
5 V5B5PH5 27.7 39.32 45.77 53.98 65.34 63.49 
6 V6B6PH6 8.73 12.12 22.57 31.09 38.98 125.00 
7 V7B7PH7 22.65 33.73 46.89 53.92 63.23 59.92 
8 Ascorbic 
acid(Standard) 
48.01 69.94 78.76 89.32 94.56 11.20 
 
 
 Arora et al                                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):343-347 
ISSN: 2250-1177                                                                                  [345]                                                                                 CODEN (USA): JDDTAO 
In Vivo Anti-Inflammatory Activity 
The anti-inflammatory activities of the compounds were 
determined by using Carrageenan induced paw edema 
method. Adult male rats (≈ 250g) were used to evaluate anti-
inflammatory activity. Ten groups were made each having 
six animals. The different groups of rats were pre-treated 
with their respective doses. After 1 hour, oedema was 
induced by administration of 0.1 ml of 1% carrageenan 
suspension into sub-plantar region of left hind paw of each 
rat and paw volume was measured by using Plethysmometer 
(Laboratory enterprises, Nasik), at 0, 1, 2, 3, 4 hr interval. 
Mean ± SEM for treated and control animals is calculated 
and compared for each time interval and were statistically 
analyzed. 
Group I: Normal control 
Group II: Inflammation control group received vehicle 
(0.25% Carboxymethylcellulose). 
Group III: Standard group treated with Diclofenac sodium 
(100 mg/kg p.o.) 
Group IV: Inflammation + V1B1PH1 (100 mg/kg p.o.) 
Group V: Inflammation + V2B2PH2 (100 mg/kg p.o.) 
Group VI: Inflammation + V3B3PH3 (100 mg/kg p.o.) 
Group VII: Inflammation + V4B4PH4 (100 mg/kg p.o.) 
Group VIII: Inflammation + V5B5PH5 (100 mg/kg p.o.) 
Group IX: Inflammation + V6B6PH6 (100 mg/kg p.o.) 
Group X: Inflammation + V7B7PH7 (100 mg/kg p.o.) 
Diclofenac sodium was used as a standard drug. The adult 
male rats were fasted overnight with free access to water. 
The standard drug was taken in the concentration of 
20mg/kg. The synthesized compounds were given at the 
dose of 150mg/kg and were administered via oral route. A 
1% suspension of carrageenan was prepared in saline. 
0.05ml of this suspension was injected into the planter 
tissue of left hind paw to induce edema. For control the 
animals were injected with equal volumes of saline and the 
paw volume of rats was measured. Results are given in the 
table 4. The compoundsV4B4PH4 and V7B7PH7 show 
remarkable anti-inflammatory activity. 
 
Table 4: Anti-inflammatory activity of 1,3,5-trisubstituted Pyrazole derivatives 
 
Treatment group 
                                   Paw volume (mm) after time (hrs) 
0 hr 1 hr 2hr 3hr 4hr 
V1B1PH1 0.92±0.049 1.16±0.080 1.20±0.067 1.27±0.046 1.29±0.024 
V2B2PH2 0.96±0.095 1.18±0.071 1.26±0.051 1.30±0.035 1.36±0.078 
V3B3PH3 0.99±0.038 1.19±0.077 1.28±0.037 1.32±0.015 1.38±0.039 
V4B4PH4 0.66±0.045 0.72±0.034 0.80±0.031 0.82±0.021 0.88±0.045 
V5B5PH5 0.90±0.084 1.12±0.065 1.22±0.052 1.28±0.039 1.36±0.047 
V6B6PH6 0.86±0.022 1.05±0.047 1.12±0.050 1.22±0.056 1.26±0.030 
V7B7PH7 0.90±0.067 1.04±0.036 1.06±0.081 1.12±0.062 1.14±0.083 
CONTROL 0.80±0.026 0.81±0.025 0.82±0.017 0.82±0.019 0.81±0.023 
Infalmmatory Control 0.96±0.028 1.14±0.066 1.24±0.043 1.30±0.042 1.38±0.054 
Diclofenac 0.86±0.012 0.96±0.012 0.92±0.012 0.84±0.019 0.82±0.016 
Values are expressed as mean ± SEM (standard error mean) 
Values are calculated as compared to control using one way ANOVA followed by Dunnet’s test 
 
Experimental Section 
Melting points of the synthesized compounds were 
determined by open capillary method and were uncorrected. 
TLC was done to check the purity and to monitor the 
reaction. The IR spectra were recorded on Shimadzu FTIR 
8400 spectrophotometer using potassium bromide pallet. 
1HNMR spectra were obtained in CDCl3 on a Bruker 
Spectrometer at 400 Hz. The chemical shifts are reported in 
ppm (δ) in relation to Tetramethylsilane (TMS) as an 
internal standard.  Coupling constants (J) are expressed in 
Hertz (Hz). All the chemicals and reagents used were 
procured from Merck and Sigma Aldrich. 
Synthesis  
1) General procedure for the synthesis of α-β-
Dibromochalcones from chalcones 
 Chalcone (0.005mmol) and tetrabutylammonium 
tribromide (TBABr3) (0.005mmol) were dissolved in 100ml 
of chloroform. The reaction mixture was sonicated at room 
temperature until discoloration of the solution (red colored 
to yellowish to colorless) took place. Completion of the 
reaction was confirmed by TLC using diethyl ether-hexane 
(20:80) as mobile phase. The solvent was evaporated and 
the residue was dissolved in diethyl ether, washed with 
aqueous 5% sodium thiosulphate solution and water. Final 
product was precipitated out by the addition of small 
amount of ethanol. (V1B1-V7B7) 
1.1.   2,3-dibromo-1-(naphthalene-6-yl)-3-
phenylpropan-1-one (V1B1) 
IR (max, in KBr): 1678 cm-1 (CO stretch); 1H NMR (CDCl3, 
300 MHz, ):  5.73 (d, 1H(α), CH, J = 8.1 Hz); 5.66 (d, 1H(β), 
CH, J = 8.1 Hz); 7.12-7.14 (m, 2H, ArH); 7.08-7.21 (m, 3H, 
ArH); 7.42-8.31(m,7H,ArH); Elemental analysis: Calculated 
for C20H7Br2O;  C 55.46, H 3.96 Found C 56.76, H 1.67 
1.2.    2,3-dibromo-3-(4-Chlorophenyl)-1-(naphthalene-
6-yl)propan-1-one (V2B2) 
IR (max, in KBr): 1680 cm-1 (CO stretch); 1H NMR (CDCl3, 
300 MHz, ): 5.55 (d, 1H(α), CH, J = 8.1 Hz); 5.45 (d, 1H(β), 
CH, J = 8.1 Hz); 7.31 (d, 2H, ArH, J = 8.4 Hz); 7.53 (d, 2H, ArH, 
J = 8.4 Hz); 7.41-8.29 (m,7H,ArH); Elemental analysis: 
Calculated for C20H16Br2OCl; C 51.37, H 3.45 Found C 51.35, 
H 3.40 
1.3.    2,3-dibromo-1-(naphthalene-6-yl)-3-(4-
nitrophenyl)propan-1-one (V3B3) 
IR (max, in KBr): 1674 cm-1 (CO stretch) ;1H NMR (CDCl3, 
300 MHz, ): 5.73 (d, 1H, CH, J = 8.1 Hz); 5.66 (d, 1H, CH, J = 
8.1 Hz); 7.38 (d, 2H, ArH, J = 8.4 Hz); 8.14 (d, 2H, ArH, J = 8.4 
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Hz); 7.43-8.31 (m,7H,ArH); Elemental analysis: Calculated 
for C20H16Br2NO3 ; C 50.24, H 3.37 Found C 50.22, H 3.35 
1.4.    2,3-dibromo-3-(4-methoxyphenyl)-1-
(naphthalene-6-yl)propan-1-one (V4B4) 
IR (max, in KBr): 1680 cm-1 (CO stretch); 1H NMR (CDCl3, 
300 MHz, ): 3.73 (s, 3H, OCH3); 5.72 (d, 1H(α), CH, J = 8.1 
Hz); 5.60 (d, 1H(β), CH, J = 8.1 Hz); 6.72-7.01 (m, 4H, ArH); 
7.39-8.296 (m,7H,ArH); Elemental analysis: Calculated for 
C21H19Br2O2; C 54.45, H 4.13 Found C 54.43, H 4.14 
1.5.    2,3-dibromo-3-(4-fluorophenyl)-1-(naphthalene-
6-yl)propan-1-one (V5B5) 
IR (max, in KBr): 1674 cm-1 (CO stretch); 1H NMR (CDCl3, 
300 MHz, ): 5.55 (d, 1H(α), CH, J = 8.1 Hz); 5.45 (d, 1H(β), 
CH, J = 8.1 Hz); 7.30 (d, 2H, ArH, J = 8.4 Hz); 7.55 (d, 2H, ArH, 
J = 8.4 Hz); 7.39-8.28 (m,7H,ArH); Elemental analysis: 
Calculated for C20H16Br2OF; C 53.25, H 3.57 Found C 53.22, H 
3.58 
1.6.    2,3-dibromo-1-(naphthalene-6-yl)-3-p-tolyl-
propan-1-one (V6B6) 
IR (max, in KBr): 1681 cm-1 (CO stretch) 
1H NMR (CDCl3, 300 MHz, ): 2.35 (s, 3H, CH3); 5.73 (d, 
1H(α), CH, J = 8.1 Hz); 5.66 (d, 1H(β), CH, J = 8.1 Hz); 7.17-
7.27 (m, 4H, ArH); 7.40-8.32 (m,7H,ArH); Elemental analysis: 
Calculated for C21H19Br2O; C 56.40, H 4.28 Found C 56.38, H 
4.27 
1.7.   2,3-dibromo-3-(4-hydroxyphenyl)-1-(naphthalene-
6-yl)propan-1-one (V7B7) 
IR (max, in KBr): 1674 cm-1 (CO stretch); 1H NMR (CDCl3, 
300 MHz, ): 5.55 (d, 1H(α), CH, J = 8.1 Hz); 5.45 (d, 1H(β), 
CH, J = 8.1 Hz); 7.31 (d, 2H, ArH, J = 8.4 Hz); 7.53 (d, 2H, ArH, 
J = 8.4 Hz); 7.42-8.30 (m,7H,ArH); 6.68-6.95 (m, 4H, ArH); 
5.00 (s, 1H,OH); Elemental analysis: Calculated for 
C21H20O2Br2; C 54.34, H 4.34 Found C 54.32, H 4.32 
2.  General procedure for the synthesis of 1,3,5 
trisubstituted Pyrazoles from α-β  chalcone dibromides  
A mixture of chalcone dibromide (0.556 g, 0.001mol) and 
phenylhydrazine hydrochloride (0.162 g, 0.0015mol) in 
ethanol was refluxed for about 3 hrs. The mixture was 
poured onto ice-cold water. Resulting mixture was then 
extracted with dichloromethane in three portions (3  50 
ml). The organic extract was dried over anhydrous sodium 
sulphate and filtered. Dichloromethane was evaporated in 
vacuum to give the crude product, which was purified by 
column chromatography on silica gel (100-200 mesh) by 
using pet ether-ethyl acetate as an eluent to give pure 
pyrazoles (V1B1PH1-V7B7PH7). 
2.1   5-(naphthalen-1-yl)-1,3-diphenyl-1H-pyrazole 
(V1B1PH1) 
IR (max, in KBr): Peak absent in CO region; 1H NMR (CDCl3, 
300 MHz, ): 7.25-7.34 (m, 4H, ArH); 7.68 (s, 1H, C3-pyrazole 
proton); 7.23-7.33 (m, 10H, ArH); 6.60-6.98 (m,7H,ArH); 
Elemental analysis: Calculated for C25H18N2; C 86.68, H 5.24 
Found C 86.67, H 5.24 
2.2    3-(4-Chlorophenyl)-5-(naphthalen-1-yl)-1phenyl-
1H-pyrazole (V2B2PH2) 
IR (max, in KBr): Peak absent in CO region; 1H NMR (CDCl3, 
300 MHz, ): 7.03 (d, 2H, ArH, J = 8.1 Hz); 7.23 (d, 2H, ArH, J 
= 8.1 Hz); 7.29-7.35 (m, 5H, ArH); 7.81 (s, 1H, C3- pyrazole 
proton); 6.60-6.98 (m,7H,ArH); Elemental analysis: 
Calculated for C25H17N2Cl; C 78.84, H 4.50 Found C 78.82, H 
4.50 
2.3   5-(naphthalen-1-yl)- 3-(4-Nitrophenyl)-1-phenyl-
1H-pyrazole (V3B3PH3) 
IR (max, in KBr): Peak absent in CO region; 1H NMR (CDCl3, 
300 MHz, ): 6.89 (d, 2H, ArH, J = 8.1 Hz); 7.21 (d, 2H, ArH, J 
= 8.1 Hz); 7.18-7.25 (m, 5H, ArH); 7.68 (s, 1H, C3- pyrazole 
proton); 6.58-6.81 (m,7H,ArH); Elemental analysis: 
Calculated for C25H17N3 O2; C76.71, H 4.38 Found C 76.70, H 
4.38 
2.4    3-(4-methoxyphenyl)-5-(naphthalen-1-yl)-
1phenyl-1H-pyrazole V4B4PH4) 
IR (max, in KBr): Peak absent in CO region; 1H NMR (CDCl3, 
300 MHz, ): 6.91 (d, 2H, ArH, J = 8.1 Hz); 7.26 (d, 2H, ArH, J 
= 8.1 Hz); 7.29-7.35 (m, 5H, ArH); 7.67 (s, 1H, C3- pyrazole 
proton); 6.60-6.98 (m,7H,ArH); 3.81 (s, 3H, OCH3); Elemental 
analysis: Calculated for C26H20N2O; C 82.95, H 5.35 Found C 
82.94, H 5.36 
2.5    3-(4-fluorophenyl)-5-(naphthalen-1-yl)-1phenyl-
1H-pyrazole (V5B5PH5) 
IR (max, in KBr): Peak absent in CO region; 1H NMR (CDCl3, 
300 MHz, ): 7.02 (d, 2H, ArH, J = 8.1 Hz); 7.21 (d, 2H, ArH, J 
= 8.1 Hz); 7.19-7.25 (m, 5H, ArH); 7.79 (s, 1H, C3- pyrazole 
proton); 6.58-6.89 (m,7H,ArH); Elemental analysis: 
Calculated for C25H17FN2; C 82.40, H 4.70 Found C 82.39, H 
4.71 
2.6    5-(naphthalen-1-yl)-1phenyl-3-p-tolyl-1H-pyrazole 
(V6B6PH6) 
IR (max, in KBr): Peak absent in CO region; 1H NMR (CDCl3, 
300 MHz, ): 7.14 (d, 2H, ArH, J = 8.1 Hz); 7.26 (d, 2H, ArH, J 
= 8.1 Hz); 7.49-7.58 (m, 5H, ArH); 7.69 (s, 1H, C3- pyrazole 
proton); 6.60-6.98 (m,7H,ArH); 2.33 (s, 3H, CH3); Elemental 
analysis: Calculated for C26H20N2; C 86.64, H 5.59 Found C 
86.63, H 5.60 
2.7    4-(5-(naphthalen-1-yl)-1-phenyl-1H-pyrazole-3-yl) 
phenol (V7B7PH7) 
IR (max, in KBr): Peak absent in CO region; 1H NMR (CDCl3, 
300 MHz, ): 7.02 (d, 2H, ArH, J = 8.1 Hz); 7.13 (d, 2H, ArH, J 
= 8.1 Hz); 7.39-7.65 (m, 5H, ArH); 7.75 (s, 1H, C3- pyrazole 
proton); 6.54-6.87 (m,7H,ArH); Elemental analysis: 
Calculated for C25H18N2O; C 82.85, H 5.01 Found C 82.84, H 
5.01 
CONCLUSION 
 Different 1,3,5-trisubstituted pyrazoles were synthesized 
from chalcone dibromides and were characterized by IR, 
NMR and elemental analysis. Evaluation for antioxidant 
property was done by using DPPH free radical scavenging 
activity. The compounds V5B5PH5 and V7B7PH7 exhibited 
moderate antioxidant activity when compared with the 
standard. In vivo anti-inflammatory activity of these 
compounds showed that V4D4PH4 and V7D7PH7 possess 
good activity than the standard.  
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